Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 927 entries
Sorted by: Best Match Show Resources per page
Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer.

OncoTargets and therapy

Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K.
PMID: 24124381
Onco Targets Ther. 2013 Oct 07;6:1393-8. doi: 10.2147/OTT.S51164. eCollection 2013.

Bevacizumab when combined with chemotherapy exerts significant activity against many solid tumors through tumor angiogenesis inhibition; however, it can induce severe side effects. We report the rare case of a 27-year-old premenopausal woman with locally advanced breast cancer that...

Cite
Ono M, Ito T, Kanai T, et al. Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. Onco Targets Ther. 2013;6:1393-8doi: 10.2147/OTT.S51164.
Ono, M., Ito, T., Kanai, T., Murayama, K., Koyama, H., Maeno, K., Mochizuki, Y., Iesato, A., Hanamura, T., Okada, T., Watanabe, T., & Ito, K. (2013). Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. OncoTargets and therapy, 61393-8. https://doi.org/10.2147/OTT.S51164
Ono, Mayu, et al. "Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer." OncoTargets and therapy vol. 6 (2013): 1393-8. doi: https://doi.org/10.2147/OTT.S51164
Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K. Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. Onco Targets Ther. 2013 Oct 07;6:1393-8. doi: 10.2147/OTT.S51164. eCollection 2013. PMID: 24124381; PMCID: PMC3794845.
Copy Download .nbib Format: NLM
Population statistics and biological traits of endangered kiso horse.

Journal of equine science

Takasu M, Hiramatsu N, Tozaki T, Kakoi H, Hasegawa T, Maeda M, Kusuda S, Doi O, Murase T, Mukoyama H.
PMID: 24833989
J Equine Sci. 2011;22(4):67-72. doi: 10.1294/jes.22.67. Epub 2012 Feb 28.

The objective of this study was to clarify the current status of endangered Kiso horse, population statistics and biological traits, in order to take a step for the conservation by scientific approach. We surveyed 125 Kiso horses (86.2% of...

Cite
Takasu M, Hiramatsu N, Tozaki T, et al. Population statistics and biological traits of endangered kiso horse. J Equine Sci. 2012;22(4):67-72doi: 10.1294/jes.22.67.
Takasu, M., Hiramatsu, N., Tozaki, T., Kakoi, H., Hasegawa, T., Maeda, M., Kusuda, S., Doi, O., Murase, T., & Mukoyama, H. (2011). Population statistics and biological traits of endangered kiso horse. Journal of equine science, 22(4), 67-72. https://doi.org/10.1294/jes.22.67
Takasu, Masaki, et al. "Population statistics and biological traits of endangered kiso horse." Journal of equine science vol. 22,4 (2011): 67-72. doi: https://doi.org/10.1294/jes.22.67
Takasu M, Hiramatsu N, Tozaki T, Kakoi H, Hasegawa T, Maeda M, Kusuda S, Doi O, Murase T, Mukoyama H. Population statistics and biological traits of endangered kiso horse. J Equine Sci. 2011;22(4):67-72. doi: 10.1294/jes.22.67. Epub 2012 Feb 28. PMID: 24833989; PMCID: PMC4013974.
Copy Download .nbib Format: NLM
Hematological and biochemical reference values for the endangered kiso horse.

Journal of equine science

Takasu M, Nagatani N, Tozaki T, Kakoi H, Maeda M, Murase T, Mukoyama H.
PMID: 24834006
J Equine Sci. 2013;24(4):75-8. doi: 10.1294/jes.24.75. Epub 2013 Dec 27.

To establish blood and biochemical references for the endangered Kiso horse, blood samples were collected from 111 adult Kiso horses, 74.5% of the existing breed. The samples were analyzed for 23 hematological and biochemical parameters to determine their means...

Cite
Takasu M, Nagatani N, Tozaki T, et al. Hematological and biochemical reference values for the endangered kiso horse. J Equine Sci. 2013;24(4):75-8doi: 10.1294/jes.24.75.
Takasu, M., Nagatani, N., Tozaki, T., Kakoi, H., Maeda, M., Murase, T., & Mukoyama, H. (2013). Hematological and biochemical reference values for the endangered kiso horse. Journal of equine science, 24(4), 75-8. https://doi.org/10.1294/jes.24.75
Takasu, Masaki, et al. "Hematological and biochemical reference values for the endangered kiso horse." Journal of equine science vol. 24,4 (2013): 75-8. doi: https://doi.org/10.1294/jes.24.75
Takasu M, Nagatani N, Tozaki T, Kakoi H, Maeda M, Murase T, Mukoyama H. Hematological and biochemical reference values for the endangered kiso horse. J Equine Sci. 2013;24(4):75-8. doi: 10.1294/jes.24.75. Epub 2013 Dec 27. PMID: 24834006; PMCID: PMC4013988.
Copy Download .nbib Format: NLM
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I.
PMID: 28864997
Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 01.

INTRODUCTION: Sodium-glucose co-transporter-2 (SGLT2) inhibitors are anti-diabetic agents that improve glycemic control with a low risk of hypoglycemia and ameliorate a variety of cardiovascular risk factors. The aim of the ongoing study described herein is to investigate the preventive...

Cite
Katakami N, Mita T, Yoshii H, et al. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes Ther. 2017;8(5):999-1013doi: 10.1007/s13300-017-0292-1.
Katakami, N., Mita, T., Yoshii, H., Shiraiwa, T., Yasuda, T., Okada, Y., Umayahara, Y., Kaneto, H., Osonoi, T., Yamamoto, T., Kuribayashi, N., Maeda, K., Yokoyama, H., Kosugi, K., Ohtoshi, K., Hayashi, I., Sumitani, S., Tsugawa, M., Ohashi, M., Taki, H., Nakamura, T., Kawashima, S., Sato, Y., Watada, H., Shimomura, I. (2017). Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(5), 999-1013. https://doi.org/10.1007/s13300-017-0292-1
Katakami, Naoto, et al. "Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,5 (2017): 999-1013. doi: https://doi.org/10.1007/s13300-017-0292-1
Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Umayahara Y, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ohashi M, Taki H, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I. Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study. Diabetes Ther. 2017 Oct;8(5):999-1013. doi: 10.1007/s13300-017-0292-1. Epub 2017 Sep 01. PMID: 28864997; PMCID: PMC5630549.
Copy Download .nbib Format: NLM
Association of human epidermal growth factor receptor 2 status with ipsilateral breast tumor recurrence and resistance to endocrine therapy.

Molecular and clinical oncology

Ishitobi M, Shiba M, Nakayama T, Koyama H, Tamaki Y.
PMID: 26171193
Mol Clin Oncol. 2015 Jul;3(4):843-846. doi: 10.3892/mco.2015.534. Epub 2015 Mar 30.

The effect of prior endocrine therapy on tumor biology and clinical outcomes of locoregional recurrence remains unclear. A total of 76 patients, who underwent salvage breast surgery for estrogen receptor-positive ipsilateral breast tumor recurrence (IBTR) following breast-conserving surgery for...

Cite
Ishitobi M, Shiba M, Nakayama T, et al. Association of human epidermal growth factor receptor 2 status with ipsilateral breast tumor recurrence and resistance to endocrine therapy. Mol Clin Oncol. 2015;3(4):843-846doi: 10.3892/mco.2015.534.
Ishitobi, M., Shiba, M., Nakayama, T., Koyama, H., & Tamaki, Y. (2015). Association of human epidermal growth factor receptor 2 status with ipsilateral breast tumor recurrence and resistance to endocrine therapy. Molecular and clinical oncology, 3(4), 843-846. https://doi.org/10.3892/mco.2015.534
Ishitobi, Makoto, et al. "Association of human epidermal growth factor receptor 2 status with ipsilateral breast tumor recurrence and resistance to endocrine therapy." Molecular and clinical oncology vol. 3,4 (2015): 843-846. doi: https://doi.org/10.3892/mco.2015.534
Ishitobi M, Shiba M, Nakayama T, Koyama H, Tamaki Y. Association of human epidermal growth factor receptor 2 status with ipsilateral breast tumor recurrence and resistance to endocrine therapy. Mol Clin Oncol. 2015 Jul;3(4):843-846. doi: 10.3892/mco.2015.534. Epub 2015 Mar 30. PMID: 26171193; PMCID: PMC4486890.
Copy Download .nbib Format: NLM
Electrochemical and catalytic properties of Ni/BaCe0.75Y0.25O3-δ anode for direct ammonia-fueled solid oxide fuel cells.

ACS applied materials & interfaces

Yang J, Molouk AF, Okanishi T, Muroyama H, Matsui T, Eguchi K.
PMID: 25804559
ACS Appl Mater Interfaces. 2015 Apr 08;7(13):7406-12. doi: 10.1021/acsami.5b01048. Epub 2015 Mar 24.

In this study, Ni/BaCe0.75Y0.25O3-δ (Ni/BCY25) was investigated as an anode for direct ammonia-fueled solid oxide fuel cells. The catalytic activity of Ni/BCY25 for ammonia decomposition was found to be remarkably higher than Ni/8 mol % Y2O3-ZrO2 and Ni/Ce0.90Gd0.10O1.95. The...

Cite
Yang J, Molouk AF, Okanishi T, et al. Electrochemical and catalytic properties of Ni/BaCe0.75Y0.25O3-δ anode for direct ammonia-fueled solid oxide fuel cells. ACS Appl Mater Interfaces. 2015;7(13):7406-12doi: 10.1021/acsami.5b01048.
Yang, J., Molouk, A. F., Okanishi, T., Muroyama, H., Matsui, T., & Eguchi, K. (2015). Electrochemical and catalytic properties of Ni/BaCe0.75Y0.25O3-δ anode for direct ammonia-fueled solid oxide fuel cells. ACS applied materials & interfaces, 7(13), 7406-12. https://doi.org/10.1021/acsami.5b01048
Yang, Jun, et al. "Electrochemical and catalytic properties of Ni/BaCe0.75Y0.25O3-δ anode for direct ammonia-fueled solid oxide fuel cells." ACS applied materials & interfaces vol. 7,13 (2015): 7406-12. doi: https://doi.org/10.1021/acsami.5b01048
Yang J, Molouk AF, Okanishi T, Muroyama H, Matsui T, Eguchi K. Electrochemical and catalytic properties of Ni/BaCe0.75Y0.25O3-δ anode for direct ammonia-fueled solid oxide fuel cells. ACS Appl Mater Interfaces. 2015 Apr 08;7(13):7406-12. doi: 10.1021/acsami.5b01048. Epub 2015 Mar 24. PMID: 25804559.
Copy Download .nbib Format: NLM
Copper(I)-catalyzed intramolecular hydroalkoxylation of unactivated alkenes.

Organic letters

Murayama H, Nagao K, Ohmiya H, Sawamura M.
PMID: 25849322
Org Lett. 2015 May 01;17(9):2039-41. doi: 10.1021/acs.orglett.5b00758. Epub 2015 Apr 07.

A Cu(I)-Xantphos system catalyzed the intramolecular hydroalkoxylation of unactivated terminal alkenes, giving five- and six-membered ring ethers. This system is applicable to both primary and secondary alcohols. A reaction pathway involving the addition of the Cu-O bond across the...

Cite
Murayama H, Nagao K, Ohmiya H, et al. Copper(I)-catalyzed intramolecular hydroalkoxylation of unactivated alkenes. Org Lett. 2015;17(9):2039-41doi: 10.1021/acs.orglett.5b00758.
Murayama, H., Nagao, K., Ohmiya, H., & Sawamura, M. (2015). Copper(I)-catalyzed intramolecular hydroalkoxylation of unactivated alkenes. Organic letters, 17(9), 2039-41. https://doi.org/10.1021/acs.orglett.5b00758
Murayama, Hiroaki, et al. "Copper(I)-catalyzed intramolecular hydroalkoxylation of unactivated alkenes." Organic letters vol. 17,9 (2015): 2039-41. doi: https://doi.org/10.1021/acs.orglett.5b00758
Murayama H, Nagao K, Ohmiya H, Sawamura M. Copper(I)-catalyzed intramolecular hydroalkoxylation of unactivated alkenes. Org Lett. 2015 May 01;17(9):2039-41. doi: 10.1021/acs.orglett.5b00758. Epub 2015 Apr 07. PMID: 25849322.
Copy Download .nbib Format: NLM
Erratum: Allometric analysis of a morphological anti-predator trait in geographic populations of Japanese crucian carp.

Scientific reports

Kodama S, Fujimori H, Hakoyama H.
PMID: 28290534
Sci Rep. 2017 Mar 14;7:43973. doi: 10.1038/srep43973.

No abstract available.

Cite
Kodama S, Fujimori H, Hakoyama H. Erratum: Allometric analysis of a morphological anti-predator trait in geographic populations of Japanese crucian carp. Sci Rep. 2017;7:43973doi: 10.1038/srep43973.
Kodama, S., Fujimori, H., & Hakoyama, H. (2017). Erratum: Allometric analysis of a morphological anti-predator trait in geographic populations of Japanese crucian carp. Scientific reports, 743973. https://doi.org/10.1038/srep43973
Kodama, Sakie, et al. "Erratum: Allometric analysis of a morphological anti-predator trait in geographic populations of Japanese crucian carp." Scientific reports vol. 7 (2017): 43973. doi: https://doi.org/10.1038/srep43973
Kodama S, Fujimori H, Hakoyama H. Erratum: Allometric analysis of a morphological anti-predator trait in geographic populations of Japanese crucian carp. Sci Rep. 2017 Mar 14;7:43973. doi: 10.1038/srep43973. PMID: 28290534; PMCID: PMC5349568.
Copy Download .nbib Format: NLM
Apoptosis-mediated antiproliferative activity of friedolanostane triterpenoid isolated from the leaves of .

Biomedical reports

Subarnas A, Diantini A, Abdulah R, Zuhrotun A, Nugraha PA, Hadisaputri YE, Puspitasari IM, Yamazaki C, Kuwano H, Koyama H.
PMID: 26870339
Biomed Rep. 2016 Jan;4(1):79-82. doi: 10.3892/br.2015.532. Epub 2015 Oct 15.

The leaves of Garcinia celebica strongly inhibit the proliferation of MCF-7 human breast adenocarcinoma cell lines. The present study focused on investigating the active anticancer and antiproliferative compound from the G. celebica leaves and assessing its mechanism of action....

Cite
Subarnas A, Diantini A, Abdulah R, et al. Apoptosis-mediated antiproliferative activity of friedolanostane triterpenoid isolated from the leaves of . Biomed Rep. 2015;4(1):79-82doi: 10.3892/br.2015.532.
Subarnas, A., Diantini, A., Abdulah, R., Zuhrotun, A., Nugraha, P. A., Hadisaputri, Y. E., Puspitasari, I. M., Yamazaki, C., Kuwano, H., & Koyama, H. (2016). Apoptosis-mediated antiproliferative activity of friedolanostane triterpenoid isolated from the leaves of . Biomedical reports, 4(1), 79-82. https://doi.org/10.3892/br.2015.532
Subarnas, Anas, et al. "Apoptosis-mediated antiproliferative activity of friedolanostane triterpenoid isolated from the leaves of ." Biomedical reports vol. 4,1 (2016): 79-82. doi: https://doi.org/10.3892/br.2015.532
Subarnas A, Diantini A, Abdulah R, Zuhrotun A, Nugraha PA, Hadisaputri YE, Puspitasari IM, Yamazaki C, Kuwano H, Koyama H. Apoptosis-mediated antiproliferative activity of friedolanostane triterpenoid isolated from the leaves of . Biomed Rep. 2016 Jan;4(1):79-82. doi: 10.3892/br.2015.532. Epub 2015 Oct 15. PMID: 26870339; PMCID: PMC4726843.
Copy Download .nbib Format: NLM
A rare case of an intercostal lung herniation with fractures of the fifth and sixth ribs after thoracic surgery.

International journal of surgery case reports

Haro A, Komiya K, Taguchi Y, Nishikawa H, Kouda T, Fujishita T, Yokoyama H.
PMID: 29546020
Int J Surg Case Rep. 2017 Nov 21;41:473-476. doi: 10.1016/j.ijscr.2017.11.028. eCollection 2017.

INTRODUCTION: Lung herniation is a rare condition defined as a protrusion of the pleural-covered lung parenchyma through an abnormal defect or weakness in the thoracic wall. Postoperative lung herniation is reported to result from a preceding operation with inadequate...

Cite
Haro A, Komiya K, Taguchi Y, et al. A rare case of an intercostal lung herniation with fractures of the fifth and sixth ribs after thoracic surgery. Int J Surg Case Rep. 2017;41:473-476doi: 10.1016/j.ijscr.2017.11.028.
Haro, A., Komiya, K., Taguchi, Y., Nishikawa, H., Kouda, T., Fujishita, T., & Yokoyama, H. (2017). A rare case of an intercostal lung herniation with fractures of the fifth and sixth ribs after thoracic surgery. International journal of surgery case reports, 41473-476. https://doi.org/10.1016/j.ijscr.2017.11.028
Haro, Akira, et al. "A rare case of an intercostal lung herniation with fractures of the fifth and sixth ribs after thoracic surgery." International journal of surgery case reports vol. 41 (2017): 473-476. doi: https://doi.org/10.1016/j.ijscr.2017.11.028
Haro A, Komiya K, Taguchi Y, Nishikawa H, Kouda T, Fujishita T, Yokoyama H. A rare case of an intercostal lung herniation with fractures of the fifth and sixth ribs after thoracic surgery. Int J Surg Case Rep. 2017 Nov 21;41:473-476. doi: 10.1016/j.ijscr.2017.11.028. eCollection 2017. PMID: 29546020; PMCID: PMC5709310.
Copy Download .nbib Format: NLM
A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol.

Alzheimer's & dementia (New York, N. Y.)

Saito S, Kojima S, Oishi N, Kakuta R, Maki T, Yasuno F, Nagatsuka K, Yamamoto H, Fukuyama H, Fukushima M, Ihara M.
PMID: 29067312
Alzheimers Dement (N Y). 2016 Oct 27;2(4):250-257. doi: 10.1016/j.trci.2016.10.001. eCollection 2016 Nov.

INTRODUCTION: There are currently no effective treatments preventing conversion from mild cognitive impairment (MCI) to Alzheimer's disease. Cilostazol is a selective type-3 phosphodiesterase inhibitor that ameliorates accumulation of amyloid-β and has prevented cognitive decline in rodent models. Furthermore, cilostazol...

Cite
Saito S, Kojima S, Oishi N, et al. A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol. Alzheimers Dement (N Y). 2016;2(4):250-257doi: 10.1016/j.trci.2016.10.001.
Saito, S., Kojima, S., Oishi, N., Kakuta, R., Maki, T., Yasuno, F., Nagatsuka, K., Yamamoto, H., Fukuyama, H., Fukushima, M., & Ihara, M. (2016). A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol. Alzheimer's & dementia (New York, N. Y.), 2(4), 250-257. https://doi.org/10.1016/j.trci.2016.10.001
Saito, Satoshi, et al. "A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol." Alzheimer's & dementia (New York, N. Y.) vol. 2,4 (2016): 250-257. doi: https://doi.org/10.1016/j.trci.2016.10.001
Saito S, Kojima S, Oishi N, Kakuta R, Maki T, Yasuno F, Nagatsuka K, Yamamoto H, Fukuyama H, Fukushima M, Ihara M. A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol. Alzheimers Dement (N Y). 2016 Oct 27;2(4):250-257. doi: 10.1016/j.trci.2016.10.001. eCollection 2016 Nov. PMID: 29067312; PMCID: PMC5651350.
Copy Download .nbib Format: NLM
Early detection of myocardial dysfunction using two-dimensional speckle tracking echocardiography in a young cat with hypertrophic cardiomyopathy.

JFMS open reports

Suzuki R, Mochizuki Y, Yoshimatsu H, Niina A, Teshima T, Matsumoto H, Koyama H.
PMID: 29449957
JFMS Open Rep. 2018 Feb 08;4(1):2055116918756219. doi: 10.1177/2055116918756219. eCollection 2018.

CASE SUMMARY: A 5-month-old intact female Scottish Fold cat was presented for cardiac evaluation. Careful auscultation detected a slight systolic murmur (Levine I/VI). The findings of electrocardiography, thoracic radiography, non-invasive blood pressure measurements and conventional echocardiographic studies were unremarkable....

Cite
Suzuki R, Mochizuki Y, Yoshimatsu H, et al. Early detection of myocardial dysfunction using two-dimensional speckle tracking echocardiography in a young cat with hypertrophic cardiomyopathy. JFMS Open Rep. 2018;4(1):2055116918756219doi: 10.1177/2055116918756219.
Suzuki, R., Mochizuki, Y., Yoshimatsu, H., Niina, A., Teshima, T., Matsumoto, H., & Koyama, H. (2018). Early detection of myocardial dysfunction using two-dimensional speckle tracking echocardiography in a young cat with hypertrophic cardiomyopathy. JFMS open reports, 4(1), 2055116918756219. https://doi.org/10.1177/2055116918756219
Suzuki, Ryohei, et al. "Early detection of myocardial dysfunction using two-dimensional speckle tracking echocardiography in a young cat with hypertrophic cardiomyopathy." JFMS open reports vol. 4,1 (2018): 2055116918756219. doi: https://doi.org/10.1177/2055116918756219
Suzuki R, Mochizuki Y, Yoshimatsu H, Niina A, Teshima T, Matsumoto H, Koyama H. Early detection of myocardial dysfunction using two-dimensional speckle tracking echocardiography in a young cat with hypertrophic cardiomyopathy. JFMS Open Rep. 2018 Feb 08;4(1):2055116918756219. doi: 10.1177/2055116918756219. eCollection 2018. PMID: 29449957; PMCID: PMC5808971.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 927 entries